id	sid	tid	token	lemma	pos
cord-343677-0buclszd	1	1	key	key	NN
cord-343677-0buclszd	1	2	:	:	:
cord-343677-0buclszd	2	1	cord-343677	cord-343677	NN
cord-343677-0buclszd	2	2	-	-	HYPH
cord-343677-0buclszd	2	3	0buclszd	0buclszd	CD
cord-343677-0buclszd	2	4	authors	author	NNS
cord-343677-0buclszd	2	5	:	:	:
cord-343677-0buclszd	2	6	Roussel	Roussel	NNP
cord-343677-0buclszd	2	7	,	,	,
cord-343677-0buclszd	2	8	Yanis	Yanis	NNP
cord-343677-0buclszd	2	9	;	;	:
cord-343677-0buclszd	2	10	Raoult	Raoult	NNP
cord-343677-0buclszd	2	11	,	,	,
cord-343677-0buclszd	2	12	Didier	Didier	NNP
cord-343677-0buclszd	2	13	title	title	NN
cord-343677-0buclszd	2	14	:	:	:
cord-343677-0buclszd	3	1	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-343677-0buclszd	3	2	recommendations	recommendation	NNS
cord-343677-0buclszd	3	3	toward	toward	IN
cord-343677-0buclszd	3	4	the	the	DT
cord-343677-0buclszd	3	5	world	world	NN
cord-343677-0buclszd	3	6	:	:	:
cord-343677-0buclszd	3	7	first	first	JJ
cord-343677-0buclszd	3	8	evaluations	evaluation	NNS
cord-343677-0buclszd	3	9	date	date	NN
cord-343677-0buclszd	3	10	:	:	:
cord-343677-0buclszd	3	11	2020	2020	CD
cord-343677-0buclszd	3	12	-	-	HYPH
cord-343677-0buclszd	3	13	09	09	CD
cord-343677-0buclszd	3	14	-	-	SYM
cord-343677-0buclszd	3	15	22	22	CD
cord-343677-0buclszd	3	16	journal	journal	NN
cord-343677-0buclszd	3	17	:	:	:
cord-343677-0buclszd	3	18	New	new	JJ
cord-343677-0buclszd	3	19	Microbes	microbe	NNS
cord-343677-0buclszd	4	1	New	new	JJ
cord-343677-0buclszd	4	2	Infect	infect	NN
cord-343677-0buclszd	4	3	DOI	doi	NN
cord-343677-0buclszd	4	4	:	:	:
cord-343677-0buclszd	4	5	10.1016/	10.1016/	CD
cord-343677-0buclszd	5	1	j.nmni.2020.100759	j.nmni.2020.100759	NNP
cord-343677-0buclszd	5	2	sha	sha	NNP
cord-343677-0buclszd	5	3	:	:	:
cord-343677-0buclszd	5	4	ffab6151a7e28d9cd5d6d1de8ecaff76e030ce24	ffab6151a7e28d9cd5d6d1de8ecaff76e030ce24	NNP
cord-343677-0buclszd	5	5	doc_id	doc_id	CD
cord-343677-0buclszd	5	6	:	:	:
cord-343677-0buclszd	5	7	343677	343677	CD
cord-343677-0buclszd	5	8	cord_uid	cord_uid	NN
cord-343677-0buclszd	5	9	:	:	:
cord-343677-0buclszd	6	1	0buclszd	0buclszd	CD
cord-343677-0buclszd	7	1	nan	nan	NNP
cord-343677-0buclszd	7	2	Author	Author	NNP
cord-343677-0buclszd	7	3	list	list	NN
cord-343677-0buclszd	7	4	:	:	:
cord-343677-0buclszd	8	1	Yanis	Yanis	NNP
cord-343677-0buclszd	8	2	ROUSSEL	ROUSSEL	NNP
cord-343677-0buclszd	8	3	1,2	1,2	CD
cord-343677-0buclszd	8	4	,	,	,
cord-343677-0buclszd	8	5	Didier	Didier	NNP
cord-343677-0buclszd	8	6	RAOULT	RAOULT	NNP
cord-343677-0buclszd	8	7	1	1	CD
cord-343677-0buclszd	9	1	Today	today	NN
cord-343677-0buclszd	9	2	,	,	,
cord-343677-0buclszd	9	3	now	now	RB
cord-343677-0buclszd	9	4	that	that	IN
cord-343677-0buclszd	9	5	the	the	DT
cord-343677-0buclszd	9	6	epidemic	epidemic	NN
cord-343677-0buclszd	9	7	is	be	VBZ
cord-343677-0buclszd	9	8	in	in	IN
cord-343677-0buclszd	9	9	a	a	DT
cord-343677-0buclszd	9	10	phase	phase	NN
cord-343677-0buclszd	9	11	of	of	IN
cord-343677-0buclszd	9	12	decline	decline	NN
cord-343677-0buclszd	9	13	in	in	IN
cord-343677-0buclszd	9	14	most	most	JJS
cord-343677-0buclszd	9	15	of	of	IN
cord-343677-0buclszd	9	16	the	the	DT
cord-343677-0buclszd	9	17	hardest	hard	RBS
cord-343677-0buclszd	9	18	hit	hit	VBN
cord-343677-0buclszd	9	19	countries	country	NNS
cord-343677-0buclszd	9	20	in	in	IN
cord-343677-0buclszd	9	21	terms	term	NNS
cord-343677-0buclszd	9	22	of	of	IN
cord-343677-0buclszd	9	23	25	25	CD
cord-343677-0buclszd	9	24	mortality	mortality	NN
cord-343677-0buclszd	9	25	(	(	-LRB-
cord-343677-0buclszd	9	26	5	5	CD
cord-343677-0buclszd	9	27	)	)	-RRB-
cord-343677-0buclszd	9	28	,	,	,
cord-343677-0buclszd	9	29	we	-PRON-	PRP
cord-343677-0buclszd	9	30	can	can	MD
cord-343677-0buclszd	9	31	issue	issue	VB
cord-343677-0buclszd	9	32	initial	initial	JJ
cord-343677-0buclszd	9	33	assessments	assessment	NNS
cord-343677-0buclszd	9	34	of	of	IN
cord-343677-0buclszd	9	35	the	the	DT
cord-343677-0buclszd	9	36	treatment	treatment	NN
cord-343677-0buclszd	9	37	strategies	strategy	NNS
cord-343677-0buclszd	9	38	adopted	adopt	VBN
cord-343677-0buclszd	9	39	in	in	IN
cord-343677-0buclszd	9	40	the	the	DT
cord-343677-0buclszd	9	41	world	world	NN
cord-343677-0buclszd	9	42	26	26	CD
cord-343677-0buclszd	9	43	according	accord	VBG
cord-343677-0buclszd	9	44	to	to	IN
cord-343677-0buclszd	9	45	the	the	DT
cord-343677-0buclszd	9	46	mortality	mortality	NN
cord-343677-0buclszd	9	47	of	of	IN
cord-343677-0buclszd	9	48	each	each	DT
cord-343677-0buclszd	9	49	of	of	IN
cord-343677-0buclszd	9	50	the	the	DT
cord-343677-0buclszd	9	51	country	country	NN
cord-343677-0buclszd	9	52	.	.	.
cord-343677-0buclszd	10	1	We	-PRON-	PRP
cord-343677-0buclszd	10	2	therefore	therefore	RB
cord-343677-0buclszd	10	3	determined	determine	VBD
cord-343677-0buclszd	10	4	which	which	WDT
cord-343677-0buclszd	10	5	countries	country	NNS
cord-343677-0buclszd	10	6	27	27	CD
cord-343677-0buclszd	10	7	recommended	recommend	VBD
cord-343677-0buclszd	10	8	hydroxychloroquine	hydroxychloroquine	NN
cord-343677-0buclszd	10	9	using	use	VBG
cord-343677-0buclszd	10	10	the	the	DT
cord-343677-0buclszd	10	11	recommendations	recommendation	NNS
cord-343677-0buclszd	10	12	issued	issue	VBN
cord-343677-0buclszd	10	13	by	by	IN
cord-343677-0buclszd	10	14	the	the	DT
cord-343677-0buclszd	10	15	authorities	authority	NNS
cord-343677-0buclszd	10	16	of	of	IN
cord-343677-0buclszd	10	17	these	these	DT
cord-343677-0buclszd	10	18	28	28	CD
cord-343677-0buclszd	10	19	countries	country	NNS
cord-343677-0buclszd	10	20	and	and	CC
cord-343677-0buclszd	10	21	the	the	DT
cord-343677-0buclszd	10	22	data	datum	NNS
cord-343677-0buclszd	10	23	collected	collect	VBN
cord-343677-0buclszd	10	24	by	by	IN
cord-343677-0buclszd	10	25	the	the	DT
cord-343677-0buclszd	10	26	website	website	NN
cord-343677-0buclszd	10	27	c19study.com	c19study.com	:
cord-343677-0buclszd	10	28	as	as	IN
cord-343677-0buclszd	10	29	source	source	NN
cord-343677-0buclszd	10	30	(	(	-LRB-
cord-343677-0buclszd	10	31	Figure	figure	NN
cord-343677-0buclszd	10	32	1a	1a	CD
cord-343677-0buclszd	10	33	)	)	-RRB-
cord-343677-0buclszd	10	34	.	.	.
cord-343677-0buclszd	11	1	Following	follow	VBG
cord-343677-0buclszd	11	2	this	this	DT
cord-343677-0buclszd	11	3	29	29	CD
cord-343677-0buclszd	11	4	work	work	NN
cord-343677-0buclszd	11	5	,	,	,
cord-343677-0buclszd	11	6	we	-PRON-	PRP
cord-343677-0buclszd	11	7	established	establish	VBD
cord-343677-0buclszd	11	8	a	a	DT
cord-343677-0buclszd	11	9	second	second	JJ
cord-343677-0buclszd	11	10	map	map	NN
cord-343677-0buclszd	11	11	classifying	classify	VBG
cord-343677-0buclszd	11	12	the	the	DT
cord-343677-0buclszd	11	13	countries	country	NNS
cord-343677-0buclszd	11	14	depending	depend	VBG
cord-343677-0buclszd	11	15	on	on	IN
cord-343677-0buclszd	11	16	how	how	WRB
cord-343677-0buclszd	11	17	they	-PRON-	PRP
cord-343677-0buclszd	11	18	were	be	VBD
cord-343677-0buclszd	11	19	affected	affect	VBN
cord-343677-0buclszd	11	20	30	30	CD
cord-343677-0buclszd	11	21	by	by	IN
cord-343677-0buclszd	11	22	the	the	DT
cord-343677-0buclszd	11	23	epidemic	epidemic	NN
cord-343677-0buclszd	11	24	(	(	-LRB-
cord-343677-0buclszd	11	25	in	in	IN
cord-343677-0buclszd	11	26	number	number	NN
cord-343677-0buclszd	11	27	of	of	IN
cord-343677-0buclszd	11	28	deaths	death	NNS
cord-343677-0buclszd	11	29	per	per	IN
cord-343677-0buclszd	11	30	million	million	CD
cord-343677-0buclszd	11	31	inhabitants	inhabitant	NNS
cord-343677-0buclszd	11	32	)	)	-RRB-
cord-343677-0buclszd	11	33	,	,	,
cord-343677-0buclszd	11	34	using	use	VBG
cord-343677-0buclszd	11	35	the	the	DT
cord-343677-0buclszd	11	36	data	datum	NNS
cord-343677-0buclszd	11	37	gathered	gather	VBN
cord-343677-0buclszd	11	38	by	by	IN
cord-343677-0buclszd	11	39	the	the	DT
cord-343677-0buclszd	11	40	31	31	CD
cord-343677-0buclszd	11	41	website	website	NN
cord-343677-0buclszd	11	42	worldometers.info	worldometers.info	VBN
cord-343677-0buclszd	11	43	(	(	-LRB-
cord-343677-0buclszd	11	44	Figure	figure	NN
cord-343677-0buclszd	11	45	1b	1b	CD
cord-343677-0buclszd	11	46	)	)	-RRB-
cord-343677-0buclszd	11	47	.	.	.
cord-343677-0buclszd	12	1	32	32	CD
cord-343677-0buclszd	13	1	A	a	DT
cord-343677-0buclszd	13	2	comparison	comparison	NN
cord-343677-0buclszd	13	3	of	of	IN
cord-343677-0buclszd	13	4	these	these	DT
cord-343677-0buclszd	13	5	two	two	CD
cord-343677-0buclszd	13	6	maps	map	NNS
cord-343677-0buclszd	13	7	shows	show	VBZ
cord-343677-0buclszd	13	8	that	that	IN
cord-343677-0buclszd	13	9	developing	develop	VBG
cord-343677-0buclszd	13	10	countries	country	NNS
cord-343677-0buclszd	13	11	have	have	VBP
cord-343677-0buclszd	13	12	massively	massively	RB
cord-343677-0buclszd	13	13	turned	turn	VBN
cord-343677-0buclszd	13	14	to	to	IN
cord-343677-0buclszd	13	15	the	the	DT
cord-343677-0buclszd	13	16	use	use	NN
cord-343677-0buclszd	13	17	33	33	CD
cord-343677-0buclszd	13	18	of	of	IN
cord-343677-0buclszd	13	19	hydroxychloroquine	hydroxychloroquine	NN
cord-343677-0buclszd	13	20	,	,	,
cord-343677-0buclszd	13	21	as	as	RB
cord-343677-0buclszd	13	22	well	well	RB
cord-343677-0buclszd	13	23	as	as	IN
cord-343677-0buclszd	13	24	Asian	asian	JJ
cord-343677-0buclszd	13	25	countries	country	NNS
cord-343677-0buclszd	13	26	which	which	WDT
cord-343677-0buclszd	13	27	present	present	VBP
cord-343677-0buclszd	13	28	low	low	JJ
cord-343677-0buclszd	13	29	mortality	mortality	NN
cord-343677-0buclszd	13	30	by	by	IN
cord-343677-0buclszd	13	31	SARS	SARS	NNP
cord-343677-0buclszd	13	32	-	-	HYPH
cord-343677-0buclszd	13	33	COV2	COV2	NNP
cord-343677-0buclszd	13	34	,	,	,
cord-343677-0buclszd	13	35	despite	despite	IN
cord-343677-0buclszd	13	36	34	34	CD
cord-343677-0buclszd	13	37	the	the	DT
cord-343677-0buclszd	13	38	fact	fact	NN
cord-343677-0buclszd	13	39	that	that	IN
cord-343677-0buclszd	13	40	they	-PRON-	PRP
cord-343677-0buclszd	13	41	have	have	VBP
cord-343677-0buclszd	13	42	been	be	VBN
cord-343677-0buclszd	13	43	the	the	DT
cord-343677-0buclszd	13	44	first	first	JJ
cord-343677-0buclszd	13	45	to	to	TO
cord-343677-0buclszd	13	46	be	be	VB
cord-343677-0buclszd	13	47	affected	affect	VBN
cord-343677-0buclszd	13	48	by	by	IN
cord-343677-0buclszd	13	49	the	the	DT
cord-343677-0buclszd	13	50	epidemic	epidemic	NN
cord-343677-0buclszd	13	51	.	.	.
cord-343677-0buclszd	14	1	These	these	DT
cord-343677-0buclszd	14	2	countries	country	NNS
cord-343677-0buclszd	14	3	have	have	VBP
cord-343677-0buclszd	14	4	in	in	IN
cord-343677-0buclszd	14	5	35	35	CD
cord-343677-0buclszd	14	6	common	common	JJ
cord-343677-0buclszd	14	7	the	the	DT
cord-343677-0buclszd	14	8	early	early	JJ
cord-343677-0buclszd	14	9	adoption	adoption	NN
cord-343677-0buclszd	14	10	of	of	IN
cord-343677-0buclszd	14	11	treatments	treatment	NNS
cord-343677-0buclszd	14	12	based	base	VBN
cord-343677-0buclszd	14	13	on	on	IN
cord-343677-0buclszd	14	14	hydroxychloroquine	hydroxychloroquine	NN
cord-343677-0buclszd	14	15	and	and	CC
cord-343677-0buclszd	14	16	chloroquine	chloroquine	NN
cord-343677-0buclszd	14	17	,	,	,
cord-343677-0buclszd	14	18	whether	whether	IN
cord-343677-0buclszd	14	19	36	36	CD
cord-343677-0buclszd	14	20	or	or	CC
cord-343677-0buclszd	14	21	not	not	RB
cord-343677-0buclszd	14	22	combined	combine	VBN
cord-343677-0buclszd	14	23	with	with	IN
cord-343677-0buclszd	14	24	other	other	JJ
cord-343677-0buclszd	14	25	antivirals	antiviral	NNS
cord-343677-0buclszd	14	26	.	.	.
cord-343677-0buclszd	15	1	The	the	DT
cord-343677-0buclszd	15	2	countries	country	NNS
cord-343677-0buclszd	15	3	having	have	VBG
cord-343677-0buclszd	15	4	expressed	express	VBN
cord-343677-0buclszd	15	5	the	the	DT
cord-343677-0buclszd	15	6	concerns	concern	NNS
cord-343677-0buclszd	15	7	for	for	IN
cord-343677-0buclszd	15	8	its	-PRON-	PRP$
cord-343677-0buclszd	15	9	use	use	NN
cord-343677-0buclszd	15	10	are	be	VBP
cord-343677-0buclszd	15	11	37	37	CD
cord-343677-0buclszd	15	12	combining	combine	VBG
cord-343677-0buclszd	15	13	up	up	RP
cord-343677-0buclszd	15	14	to	to	TO
cord-343677-0buclszd	15	15	three	three	CD
cord-343677-0buclszd	15	16	antivirals	antiviral	NNS
cord-343677-0buclszd	15	17	(	(	-LRB-
cord-343677-0buclszd	15	18	6	6	CD
cord-343677-0buclszd	15	19	)	)	-RRB-
cord-343677-0buclszd	15	20	.	.	.
cord-343677-0buclszd	16	1	This	this	DT
cord-343677-0buclszd	16	2	therefore	therefore	RB
cord-343677-0buclszd	16	3	shows	show	VBZ
cord-343677-0buclszd	16	4	a	a	DT
cord-343677-0buclszd	16	5	discrepancy	discrepancy	NN
cord-343677-0buclszd	16	6	between	between	IN
cord-343677-0buclszd	16	7	the	the	DT
cord-343677-0buclszd	16	8	strategies	strategy	NNS
cord-343677-0buclszd	16	9	of	of	IN
cord-343677-0buclszd	16	10	40	40	CD
cord-343677-0buclszd	16	11	the	the	DT
cord-343677-0buclszd	16	12	Western	western	JJ
cord-343677-0buclszd	16	13	world	world	NN
cord-343677-0buclszd	16	14	and	and	CC
cord-343677-0buclszd	16	15	those	those	DT
cord-343677-0buclszd	16	16	of	of	IN
cord-343677-0buclszd	16	17	developing	develop	VBG
cord-343677-0buclszd	16	18	countries	country	NNS
cord-343677-0buclszd	16	19	and	and	CC
cord-343677-0buclszd	16	20	the	the	DT
cord-343677-0buclszd	16	21	Far	Far	NNP
cord-343677-0buclszd	16	22	East	East	NNP
cord-343677-0buclszd	16	23	,	,	,
cord-343677-0buclszd	16	24	some	some	DT
cord-343677-0buclszd	16	25	being	be	VBG
cord-343677-0buclszd	16	26	much	much	RB
cord-343677-0buclszd	16	27	more	more	JJR
cord-343677-0buclszd	16	28	41	41	CD
cord-343677-0buclszd	16	29	cautious	cautious	JJ
cord-343677-0buclszd	16	30	than	than	IN
cord-343677-0buclszd	16	31	others	other	NNS
cord-343677-0buclszd	16	32	with	with	IN
cord-343677-0buclszd	16	33	regard	regard	NN
cord-343677-0buclszd	16	34	to	to	IN
cord-343677-0buclszd	16	35	the	the	DT
cord-343677-0buclszd	16	36	use	use	NN
cord-343677-0buclszd	16	37	of	of	IN
cord-343677-0buclszd	16	38	treatments	treatment	NNS
cord-343677-0buclszd	16	39	to	to	TO
cord-343677-0buclszd	16	40	fight	fight	VB
cord-343677-0buclszd	16	41	against	against	IN
cord-343677-0buclszd	16	42	the	the	DT
cord-343677-0buclszd	16	43	epidemic	epidemic	NN
cord-343677-0buclszd	16	44	.	.	.
cord-343677-0buclszd	17	1	The	the	DT
cord-343677-0buclszd	17	2	opposite	opposite	JJ
cord-343677-0buclszd	17	3	42	42	CD
cord-343677-0buclszd	17	4	distribution	distribution	NN
cord-343677-0buclszd	17	5	of	of	IN
cord-343677-0buclszd	17	6	chloroquine	chloroquine	NN
cord-343677-0buclszd	17	7	recommendation	recommendation	NN
cord-343677-0buclszd	17	8	and	and	CC
cord-343677-0buclszd	17	9	fatality	fatality	NN
cord-343677-0buclszd	17	10	rate	rate	NN
cord-343677-0buclszd	17	11	is	be	VBZ
cord-343677-0buclszd	17	12	striking	striking	JJ
cord-343677-0buclszd	17	13	and	and	CC
cord-343677-0buclszd	17	14	may	may	MD
cord-343677-0buclszd	17	15	be	be	VB
cord-343677-0buclszd	17	16	investigated	investigate	VBN
cord-343677-0buclszd	17	17	43	43	CD
cord-343677-0buclszd	17	18	more	more	RBR
cord-343677-0buclszd	17	19	deeply	deeply	RB
cord-343677-0buclszd	17	20	.	.	.
cord-343677-0buclszd	17	21	 	 	_SP
cord-343677-0buclszd	18	1	Remdesivir	Remdesivir	NNP
cord-343677-0buclszd	18	2	and	and	CC
cord-343677-0buclszd	18	3	chloroquine	chloroquine	NN
cord-343677-0buclszd	18	4	effectively	effectively	RB
cord-343677-0buclszd	18	5	inhibit	inhibit	VBP
cord-343677-0buclszd	18	6	the	the	DT
cord-343677-0buclszd	18	7	recently	recently	RB
cord-343677-0buclszd	18	8	47	47	CD
cord-343677-0buclszd	18	9	emerged	emerge	VBD
cord-343677-0buclszd	18	10	novel	novel	JJ
cord-343677-0buclszd	18	11	coronavirus	coronavirus	NN
cord-343677-0buclszd	18	12	(	(	-LRB-
cord-343677-0buclszd	18	13	2019-nCoV	2019-ncov	CD
cord-343677-0buclszd	18	14	)	)	-RRB-
cord-343677-0buclszd	18	15	in	in	IN
cord-343677-0buclszd	18	16	vitro	vitro	FW
cord-343677-0buclszd	18	17	Breakthrough	Breakthrough	NNP
cord-343677-0buclszd	18	18	:	:	:
cord-343677-0buclszd	18	19	chloroquine	chloroquine	NN
cord-343677-0buclszd	18	20	phosphate	phosphate	NN
cord-343677-0buclszd	18	21	has	have	VBZ
cord-343677-0buclszd	18	22	shown	show	VBN
cord-343677-0buclszd	18	23	apparent	apparent	JJ
cord-343677-0buclszd	18	24	efficacy	efficacy	NN
cord-343677-0buclszd	18	25	in	in	IN
cord-343677-0buclszd	18	26	51	51	CD
cord-343677-0buclszd	18	27	treatment	treatment	NN
cord-343677-0buclszd	18	28	of	of	IN
cord-343677-0buclszd	18	29	COVID-19	covid-19	JJ
cord-343677-0buclszd	18	30	associated	associated	JJ
cord-343677-0buclszd	18	31	pneumonia	pneumonia	NN
cord-343677-0buclszd	18	32	in	in	IN
cord-343677-0buclszd	18	33	clinical	clinical	JJ
cord-343677-0buclszd	18	34	studies	study	NNS
cord-343677-0buclszd	18	35	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-343677-0buclszd	18	36	and	and	CC
cord-343677-0buclszd	18	37	azithromycin	azithromycin	NNP
cord-343677-0buclszd	18	38	as	as	IN
cord-343677-0buclszd	18	39	a	a	DT
cord-343677-0buclszd	18	40	treatment	treatment	NN
cord-343677-0buclszd	18	41	of	of	IN
cord-343677-0buclszd	18	42	55	55	CD
cord-343677-0buclszd	18	43	COVID-19	covid-19	CD
cord-343677-0buclszd	18	44	:	:	:
cord-343677-0buclszd	18	45	results	result	NNS
cord-343677-0buclszd	18	46	of	of	IN
cord-343677-0buclszd	18	47	an	an	DT
cord-343677-0buclszd	18	48	open	open	JJ
cord-343677-0buclszd	18	49	-	-	HYPH
cord-343677-0buclszd	18	50	label	label	NN
cord-343677-0buclszd	18	51	non	non	JJ
cord-343677-0buclszd	18	52	-	-	JJ
cord-343677-0buclszd	18	53	randomized	randomized	JJ
cord-343677-0buclszd	18	54	clinical	clinical	JJ
cord-343677-0buclszd	18	55	trial	trial	NN
cord-343677-0buclszd	18	56	Maps	map	NNS
cord-343677-0buclszd	18	57	and	and	CC
cord-343677-0buclszd	18	58	Trends	Trends	NNPS
cord-343677-0buclszd	18	59	:	:	:
cord-343677-0buclszd	18	60	New	new	JJ
cord-343677-0buclszd	18	61	Cases	case	NNS
cord-343677-0buclszd	18	62	of	of	IN
cord-343677-0buclszd	18	63	COVID19	COVID19	NNP
cord-343677-0buclszd	18	64	in	in	IN
cord-343677-0buclszd	18	65	World	World	NNP
cord-343677-0buclszd	18	66	Countries	Countries	NNPS
cord-343677-0buclszd	19	1	A	a	DT
cord-343677-0buclszd	19	2	pilot	pilot	NN
cord-343677-0buclszd	19	3	study	study	NN
cord-343677-0buclszd	19	4	of	of	IN
cord-343677-0buclszd	19	5	hydroxychloroquine	hydroxychloroquine	NNP
cord-343677-0buclszd	19	6	in	in	IN
cord-343677-0buclszd	19	7	treatment	treatment	NN
cord-343677-0buclszd	19	8	of	of	IN
cord-343677-0buclszd	19	9	patients	patient	NNS
cord-343677-0buclszd	19	10	with	with	IN
cord-343677-0buclszd	19	11	common	common	JJ
cord-343677-0buclszd	19	12	coronavirus	coronavirus	NN
cord-343677-0buclszd	19	13	66	66	CD
cord-343677-0buclszd	19	14	disease-19	disease-19	CD
cord-343677-0buclszd	19	15	(	(	-LRB-
cord-343677-0buclszd	19	16	COVID-19	COVID-19	NNP
cord-343677-0buclszd	19	17	)	)	-RRB-